Joyce Slingerland
Associate Director, Translational Research · University of Miami/Jackson Health System
Credentials: · · ·
History
- Present
Braman Family Breast Cancer Institute Center · University of Miami/Jackson Health System
- 1986–1989
Hematology and Medical Oncology
- 1983–1986
Internal Medicine
- 1979–1983
Research
New functional activities for the p21 family of CDK inhibitors
Genes & Development · 1997 · 1,272 citations
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Review · Nature reviews. Cancer · 2008 · Last of 3 authors · 854 citations
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
Nature Medicine · 2002 · Last of 12 authors · 786 citations
11 papers · 1 as a resident
- SW
11 papers · 5 as a resident
- TI
10 papers
7 papers
- AB
6 papers · 1 as a resident
- BH
5 papers
5 papers
5 papers
Grants
- 1997–2029
Georgetown University Lombardi Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $159.7K · Georgetown University
- 2023–2028
National Cancer Institute · R01
PI · $2.1M · Georgetown University
- 2017–2027
National Cancer Institute · R01
Contact PI · $3.5M · Georgetown University
- 2020–2025
Novel Roles for p27 as Transcriptional Co-Regulator of cJun in Stem Cells and Development
National Cancer Institute · R01
Contact PI · $2.9M · Georgetown University
Clinical trials
- 2008–2018
Principal investigator · Completed · Phase 1, Phase 2
Joyce Marie Slingerland, MD